Answers are grounded in this paper and cite their sources.
Background: The long-term immune and metabolic effects of COVID-19 in vaccinated populations remain incompletely characterized. This study aimed to analyze dynamic changes in lymphocyte subpopulations (T, B, and Natural Killer [NK] cells [TBNK]) and key metabolic indicators among college students post–Omicron infection with prior vaccination. Methods: A prospective observational cohort of 71 male students infected with the Omicron variant of COVID-19 (Beijing, China; March–April 2022) and 18 uninfected controls was followed for 2 years. TBNK subsets and metabolic parameters (uric acid, lipid profiles, β2-microglobulin) were analyzed at 3, 6, 12, and 24 months post-infection. Results: Immunologically, total lymphocytes were elevated at 3 months when compared with controls ( P = 0.0063). Total T cells declined at 6 and 12 months but rebounded by 24 months ( P < 0.0001). NK cells increased until 12 months, then declined ( P < 0.0001). B cells decreased persistently ( P < 0.05). Metabolically, uric acid and lipid parameters (total cholesterol, LDL-C, lipoprotein [a]) showed significant fluctuations, with notable increases at 1 year post-infection ( P < 0.05). β2-microglobulin levels decreased significantly over time ( P < 0.0001). Conclusion: Omicron infection induces immune and metabolic disturbances lasting at least 1 year, with gradual but incomplete recovery by 2 years. The interplay between immune dysregulation and metabolic alterations may contribute to the long-term health effects of COVID-19. Monitoring both lymphocyte and metabolic dynamics may guide the long-term management of post-COVID-19 sequelae.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: